ATE239702T1 - 2-aminochinolinderivate mit d4-agonistischer wirkung - Google Patents
2-aminochinolinderivate mit d4-agonistischer wirkungInfo
- Publication number
- ATE239702T1 ATE239702T1 AT99910210T AT99910210T ATE239702T1 AT E239702 T1 ATE239702 T1 AT E239702T1 AT 99910210 T AT99910210 T AT 99910210T AT 99910210 T AT99910210 T AT 99910210T AT E239702 T1 ATE239702 T1 AT E239702T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- amino
- substituents
- different
- same
- Prior art date
Links
- 150000005013 2-aminoquinolines Chemical class 0.000 title abstract 2
- 230000001270 agonistic effect Effects 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 3
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- -1 nitro, amino Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical group C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 102000003962 Dopamine D4 receptors Human genes 0.000 abstract 1
- 108090000357 Dopamine D4 receptors Proteins 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical group C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 125000005493 quinolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98200399 | 1998-02-09 | ||
| PCT/EP1999/000855 WO1999040068A2 (de) | 1998-02-09 | 1999-02-05 | Verfahren zum herstellen von laminat-beschichtungen und laminat-beschichtung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE239702T1 true ATE239702T1 (de) | 2003-05-15 |
Family
ID=8233375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99910210T ATE239702T1 (de) | 1998-02-09 | 1999-02-05 | 2-aminochinolinderivate mit d4-agonistischer wirkung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6281216B1 (de) |
| EP (1) | EP1054863B1 (de) |
| JP (1) | JP4530535B2 (de) |
| AT (1) | ATE239702T1 (de) |
| AU (1) | AU2925799A (de) |
| CA (1) | CA2320116C (de) |
| DE (1) | DE69907636T2 (de) |
| ES (1) | ES2196785T3 (de) |
| WO (1) | WO1999040068A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6313141B1 (en) * | 1997-06-13 | 2001-11-06 | Neurogen Corporation | 2-aminoalkylaminoquinolines as dopamine D4 ligands |
| MXPA02003979A (es) * | 1999-10-22 | 2003-01-28 | Sanofi Synthelabo | Fenil- y piridil-tetrahidro-piridinas que tiene una actividad inhibidora de tnf. |
| EP1177792A3 (de) | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten |
| FR2933977B1 (fr) * | 2008-07-18 | 2013-04-26 | Centre Nat Rech Scient | Derives heterocycliques utiles dans le traitement des maladies neurodegeneratives |
| WO2010135571A1 (en) * | 2009-05-20 | 2010-11-25 | Cylene Pharmaceuticals, Inc. | Novel protein kinase modulators |
| GB201801128D0 (en) | 2018-01-24 | 2018-03-07 | Univ Oxford Innovation Ltd | Compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5093333A (en) | 1991-04-29 | 1992-03-03 | American Home Products Corporation | N-substituted-2-aminoquinolines useful for treating hypofunction of the cholinergic system |
| AU645681B2 (en) | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| DE69524241T2 (de) * | 1994-09-30 | 2002-06-13 | Pfizer Inc., New York | 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate |
| FR2734819B1 (fr) | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
| WO1997023482A1 (en) * | 1995-12-21 | 1997-07-03 | Pfizer Inc. | 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| TW593290B (en) * | 1996-05-10 | 2004-06-21 | Janssen Pharmaceutica Nv | Alkylaminobenzothiazole and -benzoxazole derivatives |
| JP2002504125A (ja) * | 1997-06-13 | 2002-02-05 | ニューロゲン コーポレイション | ドーパミンｄ▲下４▼リガンドとしての２−アミノアルキルアミノキノリン |
-
1999
- 1999-01-05 US US09/601,765 patent/US6281216B1/en not_active Expired - Lifetime
- 1999-02-05 CA CA2320116A patent/CA2320116C/en not_active Expired - Fee Related
- 1999-02-05 ES ES99910210T patent/ES2196785T3/es not_active Expired - Lifetime
- 1999-02-05 DE DE69907636T patent/DE69907636T2/de not_active Expired - Lifetime
- 1999-02-05 AT AT99910210T patent/ATE239702T1/de active
- 1999-02-05 AU AU29257/99A patent/AU2925799A/en not_active Abandoned
- 1999-02-05 WO PCT/EP1999/000855 patent/WO1999040068A2/de not_active Ceased
- 1999-02-05 EP EP99910210A patent/EP1054863B1/de not_active Expired - Lifetime
- 1999-02-05 JP JP2000530499A patent/JP4530535B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69907636D1 (de) | 2003-06-12 |
| WO1999040068A2 (de) | 1999-08-12 |
| ES2196785T3 (es) | 2003-12-16 |
| EP1054863B1 (de) | 2003-05-07 |
| DE69907636T2 (de) | 2004-03-25 |
| JP4530535B2 (ja) | 2010-08-25 |
| EP1054863A2 (de) | 2000-11-29 |
| JP2002502843A (ja) | 2002-01-29 |
| AU2925799A (en) | 1999-08-23 |
| CA2320116C (en) | 2011-02-01 |
| US6281216B1 (en) | 2001-08-28 |
| CA2320116A1 (en) | 1999-08-12 |
| WO1999040068A3 (de) | 1999-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE331304T1 (de) | Halbleiter auf basis von substituiertem pentacen | |
| ATE366724T1 (de) | Kondensierte heterocyclische derivate | |
| DK0765314T3 (da) | Benzoheterocykliske derivater, der kan anvendes som vasopressin- eller oxytocinmodulatorer | |
| MXPA06001274A (es) | Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio. | |
| EA200300531A1 (ru) | Производные фталазинона | |
| DK0724563T3 (da) | Mellemprodukter til fremstilling af en substitueret 2,5-diamino-3-hydroxyhexan | |
| BR9307580A (pt) | Compostos processo para a preparação dos mesmos composições farmacêuticas uso de um composto e processo de tratamento de um mamífero que inclui o ser humano | |
| DE68906183D1 (de) | 2'-desoxy-5-fluoruridinderivate. | |
| EA199901062A1 (ru) | Производные хинолин-4-карбоксамида как антагонисты рецепторов нк-2 и нк-3 | |
| AR029400A1 (es) | Derivados de isoxazolcarboxamida, un metodo para su preparacion y una composicion farmaceutica que los comprende | |
| BR9401407A (pt) | Sais de metais alcalino-terrosos, sais de metais de transição e complexos de metais de transição, composição de revestimento, emprego de compostos, processos para proteger um substrato de metal e para a preparação de sais de metais e produto | |
| ATE239702T1 (de) | 2-aminochinolinderivate mit d4-agonistischer wirkung | |
| ATE367389T1 (de) | Benzisoxazolderivate mit d4-antagonistischer wirkung | |
| IT1320162B1 (it) | Derivati della tirosina ad attivita' anti leucotrienica, procedimentoper la loro preparazione e loro uso farmaceutico. | |
| EA200200727A1 (ru) | Новые производные индола | |
| FI20031455A0 (fi) | Sulfonyyliamino-peptidomimeettejä, jotka ovat aktiivisia somatostatiinireseptorialatyyppien 4 (SSTR4) ja 1 (SSTR1) suhteen | |
| ATE465153T1 (de) | Neue indazolverbindungen mit kondensiertem ring | |
| SE7609586L (sv) | N-alkyldifenylaminer | |
| EA200401099A1 (ru) | Производные гетероциклического амида | |
| DK0765322T3 (da) | Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister | |
| ES450399A1 (es) | Un procedimiento para la preparacion de un derivado de ce- fem. | |
| DE69924636D1 (de) | Verfahren zur herstellung von chiralen derivaten | |
| AR241651A1 (es) | Un procedimiento para la preparacion de derivados de nitraminodiarilsulfoxido y procedimiento para la preparacion de composiciones farmaceuticas que los contienen. | |
| TH57849A3 (th) | ไตรโซคลิคที่ถูกแทนที่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1054863 Country of ref document: EP |